Recruiting Pulmonary Embolism Studies in Overland Park
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approxim...
Vaginal Photobiomodulation for Chronic Pelvic Pain
The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to...
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
This is a two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients with progressive NF2 mutated meningiomas....
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab externo ...
About Pulmonary Embolism Clinical Trials in Overland Park
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 5 pulmonary embolism clinical trials recruiting participants in Overland Park, KANSAS. These studies are seeking a combined 655 participants. Research is being sponsored by Ipsen, Pacira Pharmaceuticals, Inc, SoLa Pelvic Therapy and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Overland Park — FAQ
Are there pulmonary embolism clinical trials in Overland Park?
Yes, there are 5 pulmonary embolism clinical trials currently recruiting in Overland Park, KANSAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Overland Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Overland Park research site will contact you about next steps.
Are clinical trials in Overland Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Overland Park studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 5 active trials in Overland Park are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov